234 related articles for article (PubMed ID: 37893173)
1. Effect of St. John's Wort (
Alzahrani MA; Ofisan SB; Alshumaymiri NI; Alghuwainem M; Altamimi M; Alali AY; Rabie M; AboSkena AK; Almaymuni K; Almannie R; Binsaleh S
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893173
[TBL] [Abstract][Full Text] [Related]
2. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.
Galeotti N
J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196
[TBL] [Abstract][Full Text] [Related]
3. Advantages and Disadvantages of Using St. John's Wort as a Treatment for Depression.
Canenguez Benitez JS; Hernandez TE; Sundararajan R; Sarwar S; Arriaga AJ; Khan AT; Matayoshi A; Quintanilla HA; Kochhar H; Alam M; Mago A; Hans A; Benitez GA
Cureus; 2022 Sep; 14(9):e29468. PubMed ID: 36299970
[TBL] [Abstract][Full Text] [Related]
4. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
Sarris J; Kavanagh DJ
J Altern Complement Med; 2009 Aug; 15(8):827-36. PubMed ID: 19614563
[TBL] [Abstract][Full Text] [Related]
5. St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
Kholghi G; Arjmandi-Rad S; Zarrindast MR; Vaseghi S
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):629-642. PubMed ID: 35294606
[TBL] [Abstract][Full Text] [Related]
6. Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility.
Capasso R; Borrelli F; Montanaro V; Altieri V; Capasso F; Izzo AA
J Urol; 2005 Jun; 173(6):2194-7. PubMed ID: 15879886
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of the herbal antidepressant St. John's wort (Hypericum perforatum) on rat gastric motility.
Capasso R; Borrelli F; Aviello G; Capasso F; Izzo AA
Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):407-14. PubMed ID: 18172613
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
Ng QX; Venkatanarayanan N; Ho CY
J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
Solomon D; Adams J; Graves N
J Affect Disord; 2013 Jun; 148(2-3):228-34. PubMed ID: 23291009
[TBL] [Abstract][Full Text] [Related]
10. Co-administration of St. John's wort and hormonal contraceptives: a systematic review.
Berry-Bibee EN; Kim MJ; Tepper NK; Riley HE; Curtis KM
Contraception; 2016 Dec; 94(6):668-677. PubMed ID: 27444983
[TBL] [Abstract][Full Text] [Related]
11. Clinical risks of St John's Wort (Hypericum perforatum) co-administration.
Soleymani S; Bahramsoltani R; Rahimi R; Abdollahi M
Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1047-1062. PubMed ID: 28885074
[TBL] [Abstract][Full Text] [Related]
12. Effect of St John's wort on bone formation in the orthopaedically expanded premaxillary suture in rats: a histological study.
Halicioglu K; Çörekçi B; Akkaş İ; Irgin C; Özan F; Yilmaz F; Türker A
Eur J Orthod; 2015 Apr; 37(2):164-9. PubMed ID: 24997024
[TBL] [Abstract][Full Text] [Related]
13. St John's wort for depression: scoping review about perceptions and use by general practitioners in clinical practice.
Forsdike K; Pirotta M
J Pharm Pharmacol; 2019 Jan; 71(1):117-128. PubMed ID: 28653745
[TBL] [Abstract][Full Text] [Related]
14. St John's wort (Hypericum perforatum) in major depression.
Shelton RC
J Clin Psychiatry; 2009; 70 Suppl 5():23-7. PubMed ID: 19909690
[TBL] [Abstract][Full Text] [Related]
15. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
Markowitz JS; DeVane CL
Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
[TBL] [Abstract][Full Text] [Related]
16. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts.
Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S
Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201
[TBL] [Abstract][Full Text] [Related]
17. St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study.
Kobak KA; Taylor LV; Bystritsky A; Kohlenberg CJ; Greist JH; Tucker P; Warner G; Futterer R; Vapnik T
Int Clin Psychopharmacol; 2005 Nov; 20(6):299-304. PubMed ID: 16192837
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of St. John's wort for major depressive disorder.
Apaydin EA; Maher AR; Shanman R; Booth MS; Miles JN; Sorbero ME; Hempel S
Syst Rev; 2016 Sep; 5(1):148. PubMed ID: 27589952
[TBL] [Abstract][Full Text] [Related]
19. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].
Schempp CM; Müller KA; Winghofer B; Schöpf E; Simon JC
Hautarzt; 2002 May; 53(5):316-21. PubMed ID: 12063742
[TBL] [Abstract][Full Text] [Related]
20. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
